These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 22537644)

  • 1. Targeting neuronal nicotinic receptors in cancer: new ligands and potential side-effects.
    Ambrosi P; Becchetti A
    Recent Pat Anticancer Drug Discov; 2013 Jan; 8(1):38-52. PubMed ID: 22537644
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Angiogenic activity of nicotinic acetylcholine receptors: implications in tobacco-related vascular diseases.
    Egleton RD; Brown KC; Dasgupta P
    Pharmacol Ther; 2009 Feb; 121(2):205-23. PubMed ID: 19063919
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relating neuronal nicotinic acetylcholine receptor subtypes defined by subunit composition and channel function.
    Nai Q; McIntosh JM; Margiotta JF
    Mol Pharmacol; 2003 Feb; 63(2):311-24. PubMed ID: 12527802
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Physical and virtual screening methods for marine toxins and drug discovery targeting nicotinic acetylcholine receptors.
    Molgó J; Aráoz R; Benoit E; Iorga BI
    Expert Opin Drug Discov; 2013 Oct; 8(10):1203-23. PubMed ID: 23919818
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Age-related changes in functional postsynaptic nicotinic acetylcholine receptor subunits in neurons of the laterodorsal tegmental nucleus, a nucleus important in drug addiction.
    Christensen MH; Kohlmeier KA
    Addict Biol; 2016 Mar; 21(2):267-81. PubMed ID: 25363563
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nicotine activates cell-signaling pathways through muscle-type and neuronal nicotinic acetylcholine receptors in non-small cell lung cancer cells.
    Carlisle DL; Liu X; Hopkins TM; Swick MC; Dhir R; Siegfried JM
    Pulm Pharmacol Ther; 2007; 20(6):629-41. PubMed ID: 17015027
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Partial agonists as therapeutic agents at neuronal nicotinic acetylcholine receptors.
    Hogg RC; Bertrand D
    Biochem Pharmacol; 2007 Feb; 73(4):459-68. PubMed ID: 16979139
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nicotine facilitates nicotinic acetylcholine receptor targeting to mitochondria but makes them less susceptible to selective ligands.
    Uspenska K; Lykhmus O; Gergalova G; Chernyshov V; Arias HR; Komisarenko S; Skok M
    Neurosci Lett; 2017 Aug; 656():43-50. PubMed ID: 28700952
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nicotinic acetylcholine receptors as drug targets.
    Hogg RC; Bertrand D
    Curr Drug Targets CNS Neurol Disord; 2004 Apr; 3(2):123-30. PubMed ID: 15078187
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nicotine at concentrations found in cigarette smokers activates and desensitizes nicotinic acetylcholine receptors in CA1 interneurons of rat hippocampus.
    Alkondon M; Pereira EF; Almeida LE; Randall WR; Albuquerque EX
    Neuropharmacology; 2000 Oct; 39(13):2726-39. PubMed ID: 11044743
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ligands of neuronal nicotinic acetylcholine receptor (nAChR): inferences from the Hansch and 3-D quantitative structure-activity relationship (QSAR) Models.
    Nicolotti O; Pellegrini-Calace M; Altomar C; Carotti A; Carrieri A; Sanz F
    Curr Med Chem; 2002 Jan; 9(1):1-29. PubMed ID: 11864064
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro and in vivo neuronal nicotinic receptor properties of (+)- and (-)-pyrido[3,4]homotropane [(+)- and (-)-PHT]: (+)-PHT is a potent and selective full agonist at α6β2 containing neuronal nicotinic acetylcholine receptors.
    Carroll FI; Navarro HA; Mascarella SW; Castro AH; Luetje CW; Wageman CR; Marks MJ; Jackson A; Damaj MI
    ACS Chem Neurosci; 2015 Jun; 6(6):920-6. PubMed ID: 25891987
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The α7 nicotinic acetylcholine receptor complex: one, two or multiple drug targets?
    Thomsen MS; Mikkelsen JD
    Curr Drug Targets; 2012 May; 13(5):707-20. PubMed ID: 22300038
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Allosteric modulation of nicotinic acetylcholine receptors.
    Chatzidaki A; Millar NS
    Biochem Pharmacol; 2015 Oct; 97(4):408-417. PubMed ID: 26231943
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nicotinic receptor agonists as neuroprotective/neurotrophic drugs. Progress in molecular mechanisms.
    Mudo G; Belluardo N; Fuxe K
    J Neural Transm (Vienna); 2007 Jan; 114(1):135-47. PubMed ID: 16906354
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Roles of nicotinic acetylcholine receptor beta subunits in function of human alpha4-containing nicotinic receptors.
    Wu J; Liu Q; Yu K; Hu J; Kuo YP; Segerberg M; St John PA; Lukas RJ
    J Physiol; 2006 Oct; 576(Pt 1):103-18. PubMed ID: 16825297
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Carbamoylcholine homologs: novel and potent agonists at neuronal nicotinic acetylcholine receptors.
    Jensen AA; Mikkelsen I; Frølund B; Bräuner-Osborne H; Falch E; Krogsgaard-Larsen P
    Mol Pharmacol; 2003 Oct; 64(4):865-75. PubMed ID: 14500743
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuronal nicotinic acetylcholine receptors as targets for drug discovery.
    Holladay MW; Dart MJ; Lynch JK
    J Med Chem; 1997 Dec; 40(26):4169-94. PubMed ID: 9435889
    [No Abstract]   [Full Text] [Related]  

  • 19. Nicotinic acetylcholine receptor signaling in atherogenesis.
    Santanam N; Thornhill BA; Lau JK; Crabtree CM; Cook CR; Brown KC; Dasgupta P
    Atherosclerosis; 2012 Dec; 225(2):264-73. PubMed ID: 22929083
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The wonderland of neuronal nicotinic acetylcholine receptors.
    Bertrand D; Terry AV
    Biochem Pharmacol; 2018 May; 151():214-225. PubMed ID: 29248596
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.